News | Pacemakers | January 26, 2016

Mechanical Stimulation of Cardiac Cells Could Make Better Pacemakers

Study reveals that direct physical contact with cardiac cells not necessary, induced beating rate continued for one hour post-stimulation

mechanical stimulation, cardiac cells, pacemakers, Technion-Israel Institute of Technology study

January 26, 2016 — In a breakthrough that could change the future of pacemakers, Technion-Israel Institute of Technology researchers have used mechanical stimulation to “train” cardiac cells to beat at a given rate.

The team’s findings, published in Nature Physics, also demonstrate for the first time that direct physical contact with the cardiac cells isn’t required to synchronize their beating. As long as the cardiac cells are in the tissue being mechanically stimulated, they are trained by the stimulation, with long-lasting effects that persist even after it is stopped.

“Cell-cell communication is essential for growth, development and function,” explained Assistant Prof. Shelly Tzlil, of the Technion Faculty of Mechanical Engineering. “We have shown that cells are able to communicate with each other mechanically by responding to deformations created by their neighbors. The range of mechanical communication is greater than that of electrical and chemical interactions. Another significant discovery is that the duration of cell pacing is greater when the stimulus is mechanical, indicating that mechanical communication induces long-term alterations within the cell.”

The stimulation was applied by an artificial “mechanical cell,” consisting of a tiny probe (with a 0.0025 cm tip diameter) that generated (via cyclical indenting and pulling) periodic deformations in the underlying substrate (cardiac tissue). The deformations mimicked those generated by a beating cardiac cell that was also in the tissue. After a brief 10-minute training period, the cardiac cell synchronized its beating rate with the mechanical cell. Furthermore, the cardiac cell maintained the induced beating rate for more than one hour after mechanical stimulation was stopped.

“In this study, we show that an isolated cardiac cell can be trained to beat at a given frequency by mechanically stimulating the underlying substrate,” said Tzlil, who led the study. “Mechanical communication plays an important role in cardiac physiology, and is essential for converting electrical pacing into synchronized beating. Impaired mechanical communication will lead to arrhythmias even when electrical conduction is working properly. The medical implication is that adding mechanical elements to electrical pacemakers will significantly improve their efficiency.”

For more information: www.ats.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now